| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658ac0c3abc3dddb0402ed60841ebc3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_636f097a7e3d371bec97470ec73d70a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a967c29e61f326a1e908eec5cbe51cf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470704168bd4eed55eef0e07b4c5023b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cbd95c2cb252f231fc5512c6a851fea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2958e059f13a3a92d0005be344893515 |
| publicationDate |
2022-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220035123-A |
| titleOfInvention |
heart failure treatment in human subjects |
| abstract |
The present invention relates to oligonucleotides which are effective inhibitors of microRNA miR-132 and to their use in medicaments, in particular in the prophylaxis or treatment of cardiac and/or fibrotic disorders in human subjects. |
| priorityDate |
2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |